Engineering Approaches to Stimulate Angiogenesis in Tissue Engineering

Hanna Ray^*
*Correspondence: Hanna Ray, Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, Szczecin, Poland, Email:

Introduction

Angiogenesis, the process of new blood vessel formation from existing vasculature, plays a crucial role in tissue engineering. Successful tissue regeneration depends not only on the replacement of damaged tissue but also on ensuring adequate blood supply to sustain the newly formed tissue. Engineering approaches to stimulate angiogenesis have thus become a focal point in advancing the field of tissue engineering. This article explores various strategies and technologies employed to promote angiogenesis, enhancing the viability and functionality of engineered tissues. Tissue engineering aims to regenerate or replace damaged tissues using a combination of cells, biomaterials and growth factors. However, one of the critical challenges in tissue engineering is the limited ability to create large, complex tissues with sufficient vascularization. Without a robust network of blood vessels, engineered tissues face limitations in oxygen and nutrient delivery, which can hinder their integration, survival and functionality post-implantation. Angiogenesis, therefore, becomes pivotal as it provides a means to induce the formation of new blood vessels within engineered tissues. This process mimics the body's natural healing mechanisms, ensuring that the engineered tissue integrates seamlessly with the host vasculature, thereby promoting its long-term viability and functionality [1].

Description

One of the most widely studied approaches to stimulate angiogenesis in tissue engineering involves the use of growth factors. Growth factors such as Vascular Endothelial Growth Factor (VEGF), Fibroblast Growth Factor (FGF) and Platelet-Derived Growth Factor (PDGF) are known to play key roles in promoting angiogenesis by stimulating endothelial cell proliferation, migration and differentiation. VEGF, in particular, has been extensively studied for its potent angiogenic effects. Researchers have incorporated VEGF into scaffolds or delivery systems to spatially and temporally control its release within the engineered tissue. This controlled release ensures that angiogenesis is induced at the desired location and in a manner conducive to tissue regeneration. FGF has also shown promise in promoting angiogenesis, especially in the context of bone tissue engineering where vascularization is crucial for proper bone formation and integration. By incorporating FGF into biomaterial scaffolds or using gene therapy techniques to deliver FGF genes directly to the target site, researchers have successfully enhanced vascularization and tissue integration in preclinical models.

Biomaterials play a crucial role in providing structural support and biochemical cues necessary for angiogenesis in tissue engineering. Porous scaffolds made from natural polymers (e.g., collagen, gelatin) or synthetic materials (e.g., polylactic acid, poly (lactic-co-glycolic acid)) are designed to mimic the Extracellular Matrix (ECM) of native tissues. These scaffolds not only provide a physical framework for cell attachment and tissue growth but also serve as reservoirs for growth factors and other bioactive molecules that promote angiogenesis.

Microvascular networks: Recent advancements in microfabrication techniques have enabled the creation of microvascular networks within biomaterial scaffolds [2]. These networks mimic the intricate architecture of natural blood vessels and facilitate the perfusion of nutrients and oxygen throughout the engineered tissue. By seeding endothelial cells and pericytes within these microvascular networks, researchers have demonstrated enhanced vascularization and improved functionality of engineered tissues in vitro and in vivo.

Another promising approach involves using decellularized ECM derived from natural tissues as scaffolds for tissue engineering. Decellularized ECM retains the native composition and architecture of the tissue, including bioactive molecules that support angiogenesis. By repopulating these scaffolds with patient-specific cells and incorporating growth factors, researchers aim to create personalized tissue constructs with enhanced vascularization and compatibility [3]. 3D bioprinting has emerged as a transformative technology in tissue engineering, offering precise control over the spatial distribution of cells, biomaterials and growth factors. Bioprinting enables the fabrication of complex, vascularized tissue constructs by depositing bioinks containing endothelial cells, supporting cells (e.g., pericytes) and growth factors in a layer-by-layer fashion. This approach allows for the creation of perfusable vascular networks within engineered tissues, thereby overcoming the limitations associated with traditional scaffold-based approaches.

Nanotechnology offers unique opportunities to enhance angiogenesis in tissue engineering through targeted delivery of growth factors, modulation of cell behavior and manipulation of biochemical signaling pathways. Nanoparticles functionalized with angiogenic factors can be designed to release these factors in a controlled manner, thereby promoting localized angiogenesis within the engineered tissue. Furthermore, nanomaterials with specific physicochemical properties can interact with endothelial cells to enhance their proliferation, migration and differentiation, facilitating the formation of functional blood vessels. Despite significant progress, several challenges remain in the field of engineering angiogenesis for tissue regeneration. These challenges include the need for better understanding of the spatiotemporal regulation of angiogenic factors, optimization of biomaterial properties to mimic the native ECM and development of scalable manufacturing techniques for clinical translation. Furthermore, the long-term stability and functionality of engineered blood vessels need to be rigorously evaluated to ensure their integration with host vasculature and sustained support of the engineered tissue [4,5].

Conclusion

In conclusion, engineering approaches to stimulate angiogenesis represent a cornerstone in advancing the field of tissue engineering. By leveraging growth factor-based strategies, biomaterial design, emerging technologies such as 3D bioprinting and nanotechnology, researchers are making significant strides towards creating vascularized tissues that closely mimic native tissues in structure and function. Continued interdisciplinary collaborations between engineers, biologists, clinicians and material scientists will be essential in overcoming current challenges and translating angiogenesis-based tissue engineering strategies from bench to bedside. Ultimately, these innovations hold promise for revolutionizing regenerative medicine by offering effective treatments for a wide range of diseases and injuries, where vascularization is a critical factor in tissue repair and regeneration.

Acknowledgment

None.

Conflict of Interest

None.

References

1. Sheu-Gruttadauria, Jessica, Paulina Pawlica, Shannon M. Klum and Sonia Wang, et al. "Structural basis for target-directed microRNA degradation." Mol Cell 75 (2019): 1243-1255.

Google Scholar, Crossref, Indexed at

2. Kozomara, Ana, Maria Birgaoanu and Sam Griffiths-Jones. "miRBase: From microRNA sequences to function." Nucleic Acids Res 47 (2019): D155-D162.

Google Scholar, Crossref, Indexed at

3. Fabbri, Muller, Leonard Girnita, Gabriele Varani and George A. Calin. "Decrypting noncoding RNA interactions, structures and functional networks." Genome Res 29 (2019): 1377-1388.

Google Scholar, Crossref, Indexed at

4. Gebert, Luca FR and Ian J. MacRae. "Regulation of microRNA function in animals." Nat Rev J Mol Cell Biol 20 (2019): 21-37.

Google Scholar, Crossref, Indexed at

5. Omar, Hany A., Ahmed T. El‐Serafi, Fatema Hersi and El‐Shaimaa A. Arafa, et al. "Immunomodulatory MicroRNAs in cancer: Targeting immune checkpoints and the tumor microenvironment." FEBS J 286 (2019): 3540-3557.

Google Scholar, Crossref, Indexed at